4% Chlorhexidine Gluconate Daily Bathing for Prevention of Hospital-acquired Infections in Intensive Care Settings — Duclorexint

Hospital Infection Clinical Trial

Official title:
Study on the Effect of the Universal Decontamination With Daily Bathing With 4% Chlorhexidine Gluconate on the Incidence of Hospital Acquired Infections in Intensive Care Units

Status Completed

Clinical Trial Summary

The study will assess the utility of 4% chlorhexidine gluconate (CHG) daily bathing to reduce hospital acquired infections in patients admitted to intensive care units. One group will be daily bathed with 4% CHG and the other group with standard soap.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03639363
Study type	Interventional
Source	University Of Perugia
Contact
Status	Completed
Phase	Phase 4
Start date	August 10, 2015
Completion date	May 2, 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03665467` - The Global Prevalence of Infections in Urology Study
Active, not recruiting	`NCT04328818` - Indwelling Device-associated Biofilms
Recruiting	`NCT04995133` - Colistin Intravenous Administration in Critically Ill Patients Suffering From Hospital Infections Caused by Multi-antibiotic-resistant Germs.	Phase 4
Not yet recruiting	`NCT06103500` - Integrated Clinical Decision Support for Empiric Antibiotic Selection in Sepsis	N/A
Completed	`NCT06199804` - Toy Hygiene Education For Hospitalized Mothers	N/A
Recruiting	`NCT04920240` - Application of Standardized Cleaning and Disinfection Mode of HFT Surface in Hospital Infection Prevention and Control	N/A
Recruiting	`NCT02328183` - Efficacy of Polymyxin B Against Infections Caused by Extensively Drug-resistant (XDR) Gram-Negative Bacteria	Phase 4